Nicotine metabolite ratio predicts smoking topography and carcinogen biomarker level.
about
The ability of plasma cotinine to predict nicotine and carcinogen exposure is altered by differences in CYP2A6: the influence of genetics, race, and sexPharmGKB summary: very important pharmacogene information for cytochrome P-450, family 2, subfamily A, polypeptide 6Systematic and meta-analytic review of research examining the impact of menstrual cycle phase and ovarian hormones on smoking and cessation.Drug Metabolizing Enzyme and Transporter Gene Variation, Nicotine Metabolism, Prospective Abstinence, and Cigarette ConsumptionAddictions Neuroclinical Assessment: A reverse translational approach.Cotinine and trans 3'-hydroxycotinine in dried blood spots as biomarkers of tobacco exposure and nicotine metabolism.Association of CYP2A6 activity with lung cancer incidence in smokers: The multiethnic cohort studyPrecision Medicine for Tobacco Dependence: Development and Validation of the Nicotine Metabolite RatioVariability in Puff Topography and Exhaled CO in Waterpipe Tobacco Smoking.Utility and cutoff value of hair nicotine as a biomarker of long-term tobacco smoke exposure, compared to salivary cotinineKnown and novel sources of variability in the nicotine metabolite ratio in a large sample of treatment-seeking smokersThe effect of menthol on cigarette smoking behaviors, biomarkers and subjective responses.Variation in trans-3'-hydroxycotinine glucuronidation does not alter the nicotine metabolite ratio or nicotine intake.Fifty years of tobacco carcinogenesis research: from mechanisms to early detection and prevention of lung cancerAssociation of the nicotine metabolite ratio and CHRNA5/CHRNA3 polymorphisms with smoking rate among treatment-seeking smokersNIH electronic cigarette workshop: developing a research agenda.A Genome-Wide Association Study of a Biomarker of Nicotine Metabolism.Rapid nicotine clearance is associated with greater reward and heart rate increases from intravenous nicotineReproducibility of the nicotine metabolite ratio in cigarette smokers.Effects of 21 days of varenicline versus placebo on smoking behaviors and urges among non-treatment seeking smokers.High dose transdermal nicotine for fast metabolizers of nicotine: a proof of concept placebo-controlled trial.Nicotine intake and smoking topography in smokers with bipolar disorderCessation of alcohol consumption decreases rate of nicotine metabolism in male alcohol-dependent smokersA Randomized Controlled Trial of Progressively Reduced Nicotine Content Cigarettes on Smoking Behaviors, Biomarkers of Exposure, and Subjective Ratings.Genome-Wide Association of the Laboratory-Based Nicotine Metabolite Ratio in Three Ancestries.CYP2A6 genotype and smoking behavior in current smokers screened for lung cancerStability of the nicotine metabolite ratio in smokers of progressively reduced nicotine content cigarettes.Genetic determinants of CYP2A6 activity across racial/ethnic groups with different risks of lung cancer and effect on their smoking intensityTransient compensatory smoking in response to placebo cigarettesCredibility of a smoking questionnaire based on urine cotinine level for patients with bladder cancer - a preliminary report.Smoking topography in Korean American and white men: preliminary findings.Correlation between Cigarette Smoking and Urine Cotinine Level in Gastric Cancer Patients.Systematic review of the relationship between the 3-hydroxycotinine/cotinine ratio and cigarette dependence.Use of hormonal contraceptives and smoking cessation: A preliminary report.Distribution of polymorphic variants of CYP2A6 and their involvement in nicotine addiction.Smoking Through a Topography Device Diminishes Some of the Acute Rewarding Effects of Smoking.Racial differences in the relationship between rate of nicotine metabolism and nicotine intake from cigarette smoking.Nicotine Metabolite Ratio Is Associated With Lozenge Use But Not Quitting in Smokeless Tobacco Users.Nicotine Metabolite Ratio (NMR) Prospectively Predicts Smoking Relapse: Longitudinal Findings From ITC Surveys in Five Countries.Variation in CYP2A6 Activity and Personalized Medicine.
P2860
Q24595571-97037426-B8C4-4CEE-A767-99B7CD9FE192Q27012807-FDFB6930-571E-4635-97E3-0E3E82646C8EQ27690906-F5D7A5F6-0C44-4A04-B7BB-866769CDF079Q28397614-AA7A7A25-27A0-4215-8073-0821E435A285Q30399803-59EDFEC6-8B1F-42C3-8E32-AA7724A9AC9AQ33723087-78F33F51-11AE-4AED-B4AF-B50F352DB3DFQ33728649-A0FFF950-20DD-42B7-B8BE-4DA6960D86F2Q33821233-F83D55E8-EF5E-409A-B331-0A6D99F03956Q33848151-F4837846-A856-4B66-98B7-F7FECCAD76BAQ34086169-A90D7798-2CB6-49C0-8773-1A7E12114C77Q34135377-9B334972-FD4B-4C71-B864-7851B3F98A9EQ34555197-EE326933-6DE6-47F4-9BDD-E7DA6D079E9AQ34926339-4B686A7E-ACD6-4309-BC5F-E8B79AEA89F9Q34976530-BB41C43E-75F1-4079-8F64-6A746A930DA8Q35012346-F158CF0D-ED16-4E29-8045-530238AC74EFQ35029312-7D86F61C-4C92-49E8-B0FE-482587BDA7BCQ35788753-3D743955-ADC4-440F-BE54-D05870755B33Q35892758-0EB62969-EE94-4B1B-9796-592A4397D8F7Q36084196-468218A1-975B-44DA-8F79-430A025A08A8Q36479392-3904987E-E288-4C60-9C61-1DE2369CBD33Q36534993-AC349F6F-5839-4262-921C-47684898BF18Q36810188-3226F810-48C4-4737-BDD9-13008BE7C0FCQ36936189-5C9C68A5-9871-4F9B-8031-6A1878B81827Q37059838-88AB490B-E489-45C9-B85A-FB4AA58599AEQ37163230-EF11E0C6-65D1-45D6-AC41-44C8F35800C2Q37210919-CEC0956A-260A-4346-9775-54FFE04E971FQ37215518-876EC1DF-8AC1-4F80-8AFB-7FAE0909C98FQ37238137-95122756-027B-4045-B8B2-6B8BC0667B07Q37242430-0FCC12BF-EDD6-4D5C-AE7B-784DCB1EBD97Q37579076-DF08C28A-8B45-4F9D-BB4E-7B73A3119F98Q37666211-2A3B9E66-39BD-4847-BC17-4AE519EDA569Q37700687-5B739972-769C-4F7D-8D11-1385DC0F29B8Q37877612-82487519-40BF-4F7D-AD81-0C6059CE4933Q38597751-621DFA68-7EEC-4975-A6A9-F16F8C38D090Q38683483-2A042D99-67D0-44BB-9EB1-0307A28CF74EQ38981327-4E7C81D3-D4FB-4626-9FD7-AA0943649723Q39765572-9BD423D4-5B27-49EA-B77D-EDE11B49FB9FQ40936765-9C47E48D-7F19-4BE7-9A6A-365316255100Q46586422-EF84761B-A2B9-422F-A597-49CF33DB9C64Q47163198-2D90D2BE-0CF9-4C99-B25D-0BD17E195DA9
P2860
Nicotine metabolite ratio predicts smoking topography and carcinogen biomarker level.
description
2011 nî lūn-bûn
@nan
2011 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Nicotine metabolite ratio predicts smoking topography and carcinogen biomarker level.
@ast
Nicotine metabolite ratio predicts smoking topography and carcinogen biomarker level.
@en
Nicotine metabolite ratio predicts smoking topography and carcinogen biomarker level.
@nl
type
label
Nicotine metabolite ratio predicts smoking topography and carcinogen biomarker level.
@ast
Nicotine metabolite ratio predicts smoking topography and carcinogen biomarker level.
@en
Nicotine metabolite ratio predicts smoking topography and carcinogen biomarker level.
@nl
prefLabel
Nicotine metabolite ratio predicts smoking topography and carcinogen biomarker level.
@ast
Nicotine metabolite ratio predicts smoking topography and carcinogen biomarker level.
@en
Nicotine metabolite ratio predicts smoking topography and carcinogen biomarker level.
@nl
P2093
P2860
P1476
Nicotine metabolite ratio predicts smoking topography and carcinogen biomarker level.
@en
P2093
Andrew A Strasser
Angela G Pinto
Caryn E Lerman
Kathy Z Tang
Neal L Benowitz
Rachel F Tyndale
Stephen S Hecht
Steve G Carmella
P2860
P304
P356
10.1158/1055-9965.EPI-10-0674
P577
2011-01-06T00:00:00Z